News&Events – BioMAdvanced Diagnostics

2023/05/11/ – Design Freeze for our lung rejection test
2023/03/27 – Kidney International publishes ground breaking article authored by our co-founders Sophie Brouard and Richard Danger supporting BMAD’s technology
2023/03/24 – Design freeze of our software platform
2023/03/09 – Evosciences has agreed to finance most of our laboratory equipment.
2023/02/23 – Airbus Développement to support BioMAdvanced Diagnostics
2023/02/14 – Eurofins Genomics accepts to deliver to us oligonucleotides under an OEM agreement
2023/02/04 – BioMAdvanced Diagnostics has received a €900K grant from BPI France which confirms its “DeepTech” status.
2022/09/30 – BioMAdvanced Diagnostics welcomes Mr Steven Roblin as its new Laboratory Technician reporting to Marion cadoux
2022/09/27 – BioMAdvanced Diagnostics raises €1,7 million to develop its diagnostics solutions and contribute to improving the life of patients having received a kidney or lung transplant
2022/09/14 – BioMAdvanced Diagnostics welcomes Mrs Caroline Legal as its new Regulatory Affairs Engineer, reporting to Madeleine Rambeau
2022/09/01 – BioMAdvanced Diagnostics is extremely proud to announce the Design Freeze of its IVD test for Transplant kidney rejection!
2022/06/30 – BioMAdvanced Diagnostics enters an agreement with Nantes’ University Hospital to analyze anonymized clinical data from 300 kidney transplant data for its 1st Clinical Performance Study
2022/05/11 – On May 11th, 2022 BioMAdvanced Diagnostics has been selected among 200 companies to be one of the 40 French deeptech companies pitching at the Tech Tour France Transfer Invest
2022/03/07 – BioMAdvanced Diagnostics announces the appointment and start of its Quality Affairs & Regulatory Affairs Manager
2022/02/03 – BioMAdvanced Diagnostics has been granted from SATT Ouest Valorisation an exclusive license for 3 patents relating to the diagnosis of patients who have undergone kidney and/or lung transplantation
2022/01/27 – BioMAdvanced Diagnostics announces having received “DeepTech” status from La French Tech and BPI France together with a Bourse French Tech Emergence grant
2022/01/12 – BioMAdvanced Diagnostics has launched its Scientific Advisory Board
2021/12/03 – BioMAdvanced Diagnostics is one of the 11 companies supported by the Nantes Métropole Fonds Métropolitain d’innovation en santé
2021/11/25 – BioMAdvanced selected as a finalist at the Start Innovation CIC Business Awards (edition CIC Ouest)
2021/10/29 – BioMadvanced Diagnostics announces IDBC as its selected partner for the design of the Digital part of its developping offering
2021/10/19 – BioMAdvanced Diagnostics distinguished and rewarded at Start West 2021
2021/10/15 – BioMAdvanced Diagnostics announces its membership to France Biotech
2021/10/07 – BioMADvanced Diagnostics announced the support from Réseau Entreprendre Atlantique (REA)
2021/10/04 – BioMAdvanced Diagnostics announces the opening of a Quality Manager position
2021/10/01 – BioMAdvanced Diagnostics announces the hiring of its 1st Development Engineer
2021/09/28 – BioMAdvanced Diagnostics sets up part of its operation at the Faculty of Medicine and at the CRTI in Nantes
2021/09/23 – BioMAdvanced Diagnostics is revealed!